Want to see AU:MX1 full AI Analyst Report?
MX1 Stock Chart & Stats
AU$0.03
AU$0.00(0.00%)
At close: 4:00 PM EDT
AU$0.03
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.12
Previous CloseN/A
Volume167.40K
Average Volume (3M)1.31M
Market Cap
AU$33.86M
Enterprise ValueAU$29.57
Total Cash (Recent Filing)AU$3.14M
Total Debt (Recent Filing)AU$6.48M
Price to Earnings (P/E)―
Beta0.36
Next Earnings
Feb 26, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding752,436,800
10 Day Avg. Volume2,479,581
30 Day Avg. Volume1,313,798
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)4.98
Price to Sales (P/S)1.62
P/FCF Ratio-2.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.06Price Target Upside100.00% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)AU$23.00M
Bulls Say, Bears Say
Bulls Say
Proprietary Compact X-ray TechnologyMicro-X’s proprietary cold-cathode platform targets smaller, lighter and potentially lower-power X-ray products. That differentiated design objective can support adoption where portability and compact form matter, while spanning medical and security uses broadens the technology’s durable opportunities.
Revenue Has Scaled Over TimeRevenue has expanded substantially over the five years shown, indicating that Micro-X has progressed beyond an early commercial base and increased product activity. Although recent growth was uneven, the larger revenue platform can support operating leverage if product sales and deployments improve.
Diversified Technology MonetisationMicro-X can monetise its technology through complete systems, OEM components or licensing, funded development, and recurring support services. This range of routes reduces reliance on one commercial format and creates multiple ways for adoption of its X-ray platform to generate revenue.
Bears Say
Persistent Operating LossesPersistent losses and deeply negative net margins show that Micro-X has not yet demonstrated a self-sustaining earnings model. Until revenue growth translates into consistent gross profit and operating leverage, the company’s ability to fund expansion internally remains constrained.
Recurring Cash BurnNegative operating and free cash flow across the periods shown indicates that the business continues to consume cash while operating and investing. Ongoing burn can restrict investment flexibility and require external funding or available balance-sheet capacity to sustain operations.
Weakened Balance Sheet And Higher LeverageThe sharp decline in equity alongside higher debt-to-equity materially reduces financial flexibility. A smaller equity base provides less capacity to absorb continued losses, while greater leverage can increase funding pressure and constrain capital allocation during the next several quarters.
Micro-X Ltd. News
MX1 FAQ
What was Micro-X Ltd.’s price range in the past 12 months?
Micro-X Ltd. lowest share price was AU$0.01 and its highest was AU$0.12 in the past 12 months.
What is Micro-X Ltd.’s market cap?
Micro-X Ltd.’s market cap is AU$33.86M.
When is Micro-X Ltd.’s upcoming earnings report date?
Micro-X Ltd.’s upcoming earnings report date is Feb 26, 2027 which is in 151 days.
How were Micro-X Ltd.’s earnings last quarter?
Micro-X Ltd. released its earnings results on Aug 27, 2026. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of AU$0 by -AU$0.004.
Is Micro-X Ltd. overvalued?
According to Wall Street analysts Micro-X Ltd.’s price is currently Undervalued.
Does Micro-X Ltd. pay dividends?
Micro-X Ltd. does not currently pay dividends.
What is Micro-X Ltd.’s EPS estimate?
Micro-X Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Micro-X Ltd. have?
Micro-X Ltd. has 752,436,800 shares outstanding.
What happened to Micro-X Ltd.’s price movement after its last earnings report?
Micro-X Ltd. reported an EPS of -AU$0.004 in its last earnings report, missing expectations of AU$0. Following the earnings report the stock price went down -3.846%.
Which hedge fund is a major shareholder of Micro-X Ltd.?
Currently, no hedge funds are holding shares in AU:MX1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Micro-X Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$0.06 (100.00% Upside)
AU$0.06 (100.00% Upside)
Blogger Sentiment
Bullish
AU:MX1 Sentiment 100%
Sector Average 64%
Sector Average 64%
Insider Transactions
Bought Shares
Worth AU$38.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.75%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-10.81%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Micro-X Ltd.
Micro-X Limited designs, develops, manufactures, and commercializes imaging products for healthcare, defense, and security markets through cold cathode X-ray technology. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components. It also provides Rover Plus for medical performance in a mobile system; Head CT, a standard ambulance or retrieval aircraft for stroke; Checkpoints, a modular passenger self-screening checkpoint for airports; Baggage scanner, a CT baggage scanner for passenger self-screening checkpoints; Argus, a wide-area scattered projection backscatter and miniaturized high-voltage generator; and space imaging solutions. The company operates in Australia, the United States, the Asia-Pacific, Europe, the Middle East, and Africa. Micro-X Limited was incorporated in 2011 and is based in Tonsley, Australia.
MX1 Stock 12 Month Forecast
Average Price Target
AU$0.06
▲(100.00% Upside)
Technical Analysis
Compumedics Limited
―
Cyclopharm Limited
―
EMvision Medical Devices Ltd.
―
4DMedical Ltd
―
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
―